Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia- A Cost-Effectiveness Analysis
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1176
https://www.valueinhealthjournal.com/article/S1098-3015(15)01233-4/fulltext
Title :
Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia- A Cost-Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01233-4&doi=10.1016/j.jval.2015.03.1176
First page :
A203
Section Title :
Cancer
Open access? :
No
Section Order :
638